Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Respiratory syncytial virus replication inhibitors

Respiratory syncytial virus replication inhibitors

US Patent 7407969 · Granted Aug 5, 2008

Estimated economic value: $108,629,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Long-acting formulations2024
PZA and cytochrome Bc1 inhibitor combination treatment2024
PZA and cytochrome bc1 inhibitor combination treatment2022
Long-acting formulations2021
Antibacterial compounds and uses thereof2021
Ophthalmic compositions containing alcaftadine2020
Antibacterial compounds and uses thereof2019
Pyrazolyl quinoxaline kinase inhibitors2017
Pyrazolyl quinoxaline kinase inhibitors2016
Pyrazolyl quinoxaline kinase inhibitors2014
Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial vir2014
Quinoline derivatives as antibacterial agents2014